Joaquín Montalar

Randomized Phase III Study of Gemcitabine-Cisplatin Versus Etoposide-Cisplatin in the Treatment of Locally Advanced or Metastatic Non–Small-Cell Lung Cancer

Felipe Cardenal, M.P. López-Cabrerizo, Antonio Antón et al. · Journal of Clinical Oncology · 1999 · 476 citations

Medicine, Oncology, Pharmacology +10

Pretreatment prognostic factors for survival in small-cell lung cancer: A new prognostic index and validation of three known prognostic indices on 341 patients

I. Maestu, María A. Pastor, José Gómez‐Codina et al. · Annals of Oncology · 1997 · 85 citations

Medicine, Oncology, Survival Analysis +12

Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study

Yolanda Escobar, Gerardo Cajaraville, Juan Antonio Virizuela et al. · Supportive Care in Cancer · 2015 · 81 citations · Full text

Medicine, Oncology, Pharmacology +13

Circulating Endothelial Cells and Microparticles as Prognostic Markers in Advanced Non-Small Cell Lung Cancer

Tania Fleitas, Vicenta Martı́nez-Sales, Virtudes Vila et al. · PLoS ONE · 2012 · 71 citations · Full text

Medicine, Oncology, Pharmacology +16

Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation

Samuel Romero, Juan Montoro, Marta Guinot et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2018 · 63 citations

Medicine, Hematology, Pathology +11